biomedicina slovenica


"farmakokinetika" : 85

  1. Pajek Jernej; Arnol Miha; Marn-Pernat Andreja; Aleš Andreja; Mlinšek Gregor; Škoberne Andrej; Pajek Jernej; Arnol Miha; Bren Andrej; Kržan Mojca; Kveder Radoslav
    Imunosupresijska zdravljenja v nefrologiji
    2018
  2. Krieckaert Charlotte LM; Van Tubergen Astrid; Gehin Johanna Elin; Hernández-Breijo Borja; Le Mélédo Guillaume; Balsa Alejandro; Čučnik Saša
    EULAR points to consider for therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal diseases
    2022
  3. Kerec Kos Mojca
    Spremembe v farmakokinetiki pri novorojenčkih
    2022
  4. Zapotocka Ester; Batorova Angelika; Bilić Ernest; Boban Ana; Escuriola Ettingshausen Carmen; Faganel Kotnik Barbara; Hrdlickova Radomira; Laguna Pawel; Machal Jan; Preložnik-Zupan Irena
    First experience of a hemophilia monitoring platform
    2022
  5. Plaskan Urša; Kolšek Marko; Petek Davorina; Ivetić Vojislav
    Predpisovanje potencialno neprimernih zdravil v DSO Tisje
    2021
  6. Hanžel Jurij; Bukkems Laura H.; Gecse Krisztina B; D'Haens Geert; Mathôt Ron A
    Population pharmacokinetics of subcutaneous infliximab CT-P13 in Crohn's disease and ulcerative colitis
    2021
  7. McCreight Laura J.; Stage Tore B.; Connelly Paul; Lonergan Mike; Nielsen Flemming; Prehn Cornelia; Adamski Jerzy; Br Kim; Pearson Ewan R.
    Pharmacokinetics of metformin in patients with gastrointestinal intolerance
    2018
  8. Mihevc Matic; Petreski Tadej; Maver Uroš; Bevc Sebastjan
    Renal proximal tubular epithelial cells
    2020
  9. Tavčar Benković Eva; Štrukelj Borut; Razinger-Mihovec Barbara; Kržan Mojca; Peterlin-Mašič Lucija; Perković-Benedik Mirjana; Knez Lea; Sollner Dolenc Marija; Gosenca Matjaž Mirjam; Tomašič Tihomir; Kočevar Glavač Nina; Jakopin Žiga
    Uporaba kanabinoidov
    2019
  10. Kržan Mojca
    Farmakokinetika in farmakodinamika kanabinoidov
    2019
  11. Kerec Kos Mojca; Miksić Mirjana; Jovanović Marija; Roškar Robert; Grosek Štefan; Grabnar Iztok
    Maturation of midazolam clearance in critically ill children with severe bronchiolitis
    2020
  12. Muzlovič Igor
    Prednosti in slabosti neprekinjene infuzije antibiotika pri bolnikih s hudimi okužbami
    [Advantages and disadvantages of continuous infusion of antibiotic in severe infections]
    2014
  13. Borovšak Zvonko; Krčevski-Škvarč Nevenka
    Sedacija, analgezija in relaksacija v enoti za intenzivno medicino
    2019
  14. Sollner Dolenc Marija; Černe Katarina
    Kanabinoidi pod drobnogledom
    [Cannabinoids under scrutiny]
    2019
  15. Poe Michael M.; Methuku Kashi Reddy; Li Guanguan; Verma Ashwini R.; Teske Kelly A.; Stafford Douglas C.; Arnold Leggy A.; Cramer Jeffrey W.; Jones Timothy M.; Černe Rok
    Synthesis and characterization of a novel gamma-aminobutyric acid type A (GABA A ) receptor ligand that combines outstanding metabolic stability, pharmacokinetics, and anxiolytic efficacy
    2016
  16. Jereb Matjaž; Muzlovič Igor
    Okužbe pri kritično bolnih
    2015
  17. Jakopin Žiga
    Vpliv kajenja na zdravilne učinkovine
    [The effect of smoking on drugs]
    2018
  18. Kržan Mojca
    Farmakokinetika in farmakodinamika kanabinoidov rastlinskega izvora
    2018
  19. Drobne David; Bossuyt Peter; Breynaert Christine; Cattaert Tom; Casteele Niels Vande; Compernolle Griet; Jürgens Matthias; Ferrante Marc; Ballet Vera; Wollants Willem-Jan; Cleynen Isabelle; Van Steen Kristel; Gils Ann; Rutgeerts P.; Vermeire Séverine; Van Assche Gert
    Withdrawal of immunomodulators after co-treatment does not reduce trough level of infliximab in patients with Crohn's disease
    2015
  20. Rožman Samo; Grabnar Iztok; Novaković Srdjan; Mrhar Aleš; Jezeršek Novaković Barbara
    Population pharmacokinetics of rituximab in patients with diffuse large B-cell lymphoma and association with clinical outcome
    2017
  21. Žiberna Lovro
    Farmakokinetika etanola in interakcije z zdravili
    2017
  22. Rugelj Urška; Boltežar Lučka; Tavčar Petra; Jezeršek Novaković Barbara
    Farmakokinetika visokih doz metotreksata pri bolnikih z limfomi
    2016
  23. Rožman Samo
    Farmakokinetika in farmakodinamika monoklonskih protiteles
    2016
  24. Jenko Barbara; Dolžan Vita; Praprotnik Sonja
    Klinično farmakogenetski modeli za bolniku prilagojeno zdravljenje revmatoidnega artritisa
    [Clinical pharmacogenetic models for personalized rheumatoid arthritis treatment]
    2016
  25. Drobne David; Ferkolj Ivan
    Vpliv azatioprina in metotreksata na farmakokinetiko in učinkovitost infliksimaba pri zdravljenju Crohnove bolezni
    2016
  26. Jošt Anton; Kamenik Mirt
    Lajšanje porodne bolečine z remifentanilom in analiza modeliranja tarčnih koncentracij
    [Effect- site concentration of remifentanil during patient-controlled analgesia in labour]
    2016
  27. Milosheska Daniela; Lorber Bogdan; Vovk Tomaž; Kastelec Matej; Dolžan Vita; Grabnar Iztok
    Pharmacokinetics of lamotrigine and its metabolite N-2-glucuronide
    2016
  28. Locatelli Igor; Kastelec Matej; Koprivšek Jure; Kores-Plesničar Blanka; Mrhar Aleš; Dolžan Vita; Grabnar Iztok
    Population pharmacokinetics of risperidone in patients with acute schizophrenia
    2008
  29. Fornasaro Stefano; Žiberna Lovro; Gasperotti Mattia; Tramer Federica; Vrhovšek Urška; Mattivi Fulvio; Passamonti Sabina
    Determination of cyanidin 3-glucoside in rat brain, liver and kidneys by UPLC/MS-MS and its application to a short-term pharmacokinetic study
    2016
  30. Drofenik Polonca
    Zdravljenje z varfarinom
    2009
  31. Jarc Urša; Gobec Stanislav
    Načrtovanje, sinteza in vrednotenje novih naftalensulfonamidov kot potencialnih zaviralcev holineasteraz
    [Design, synthesis and evaluation of novel naphtalenesulfonamides as potential cholinesterase inhibitors]
    2015
  32. Rugelj Neža; Trobec Katja; Pišlar Mitja; Meško-Brguljan Pika; Košnik Mitja; Mrhar Aleš
    Evaluation of theophylline therapeutic drug monitoring service
    [Vrednotenje procesa terapevtskega spremljanja serumskih koncentracij teofilina]
    2015
  33. Klen Jasna; Janež Andrej; Dolžan Vita
    Vpliv genetskih polimorfizmov v presnovi sulfonilsečnin in metformina na urejenost sladkorne bolezni tipa 2
    [The influence of genetic polymorphisms in the metabolism of sulfonylureas and metformin on glycemic control in type 2 diabetic patients]
    2015
  34. Ferk Polonca
    Farmakogenomika selektivnih zaviralcev privzema serotonina
    [Pharmacogenomics of selective serotonin reuptake inhibitors]
    2010
  35. Mrhar Aleš
    Farmakokinetika zdravil za kontracepcijo in hormonsko zdravljenje
    2014
  36. Čufar Andreja
    Vpliv farmacevtske oblike zdravila na farmakokinetiko učinkovin
    [Impact of pharmaceutical dosage forms on pharmacokinetics of drugs]
    2013
  37. Vovk Tomaž
    Fiziološke posebnosti starostnikov in njihov vpliv na terapijo z zdravili
    [Impact of physiological changes on pharmacotherapy in the elderly]
    2010
  38. Vovk Tomaž; Jakovljević M.B.; Kerec Kos Mojca; Janković S.M.; Mrhar Aleš; Grabnar Iztok
    Population pharmacokinetic model of topiramate in patients with epilepsy
    2008
  39. Sonc Monika
    Farmakologija protitumorskih zdravil v sistemski terapiji zdravljenja raka s poudarkom na farmakokinetiki, farmakodinamiki in interakcijah
    2009
  40. Petre Maja
    Nova antikoagulantna zdravila
    2011
  41. Grabnar Iztok
    Farmakokinetika antikoagulacijskih zdravil pri jetrni in ledvični disfunkciji
    [Pharmacokinetics of antico[o!]agulant drugs in renal and hepatic impairment]
    2014
  42. Locatelli Igor
    Pomen farmakokinetike pri napovedovanju kliničnih učinkov antidepresivov in antipsihotikov
    [Influence of pharmacokinetic properties of antidepressants and antipsychotics on their clinical effects]
    2014
  43. Locatelli Igor
    Časovni potek resnih neželenih učinkov verapamila
    [Time course of serious adverse effects of verapamil]
    2013
  44. Kores-Plesničar Blanka; Plesničar Andrej
    Therapeutic drug monitoring and pharmacogenetics - is this a way towards creative psychopharmacotherapy?
    2014
  45. Lipnik-Štangelj Metoda
    Dokumentacija o bezbjednosti i efikasnosti, najčešće stručne dileme i greške predlagača
    2014
  46. Trdan Lušin Tina; Marc Janja; Mrhar Aleš; Trontelj Jurij; Zavratnik Andrej; Ostanek Barbara
    The association of ABCB1 polymorphism with raloxifene pharmacokinetics and pharmacodynamics
    2011
  47. Goričar Katja; Dolžan Vita
    Farmakogenetski označevalci odgovora na zdravljenje z analogi folne kisline in spojinami platine pri osteosarkomu in malignem mezoteliomu
    [Pharmacogenetic markers of response to treatmant with folic acid analogues and platinum compounds in osteosarcoma and malignant mesothelioma]
    2014
  48. Xenobiotica
    1971
  49. Marušić Maja; Komel Radovan
    Razvoj učinkovitih epitelijskih modelov za ugotavljanje prehodnosti proteinov in vitro
    [Development of effective epithelial models for assessing protein permeability in vitro]
    2013
  50. Mrhar Aleš; Grabnar Iztok
    Basic concepts of pharmacokinetics
    2013
  51. Dolžan Vita
    Farmakokinetika v medicini
    2013
  52. Faganel Barbara; Jazbec Janez; Dolžan Vita
    Vpliv genetske variabilnosti prenosa metotreksata na izid zdravljenja otrok z levkemijo
    [Influence of methotrexate transport genetic variability on treatment outcome in children with leukemia]
    2012
  53. Bukovnik Nejc; Mekiš Dušan; Križmarić Miljenko
    Pharmacokinetic and pharmacodynamic simulation of non-depolarizing muscle relaxant Rocuronium (Esmeron)
    2012
  54. Režonja Renata; Knez Lea; Čufer Tanja; Mrhar Aleš
    Oral treatment with etoposide in small cell lung cancer - dilemmas and solution
    2013
  55. Premuš-Marušič Alenka; Locatelli Igor; Mrhar Aleš
    Farmakokinetika penicilinskih antibiotikov: preklop iz intravenske na peroralno terapijo
    [Pharmacokinetics of penicillin antibiotics: intravenous-to-oral switch therapy]
    2010
  56. Kržan Mojca
    Farmakokinetika v neonatalnem obdobju
    2009
  57. Bren Andrej; Kandus Aljoša
    Mesto mikofenolata v nefrologiji
    [Place of mycophenolate in nephrology]
    2006
  58. Beović Bojana
    Novi fluorokinoloni: levofloksacin, moksifloksacin, gatifloksacin, gemifloksacin
    [New fluoroquinolones: levofloxacin, moxifloxacin, gatifloxacin, gemifloxacin]
    2004
  59. Cerkvenik-Flajs V; Grabnar I
    Farmakokinetika ivermektina
    [Ivermectin pharmacokinetics]
    2002
  60. Vodopivec-Jamšek Vlasta
    Priprava bolnikov, ki prejemajo antikoagulacijska zdravila, na načrtovani operativni poseg
    [Management of patients on anticoagulation drugs before and after elective surgery]
    2002
  61. Franić Damir
    Farmakokinetika in farmakodinamika tokolitikov
    [Pharmacodynamics and pharmacokynetics of tocolytic drugs]
    2001
  62. Lenardič A; Cvelbar P; Kopitar Z
    Farmakokinetika večkratnega doziranja pipemidinske kisline
    1984
  63. Mrhar A; Karba R; Kozjek F
    FARMAKOKINETIKA URINARNIH ANTISEPTIKA
    1980
  64. Mrhar Aleš
    Farmakokinetika zdravil za ginekološka obolenja
    2000
  65. Kozjek Franc; Manček Bronja
    Populacijska farmakokinetika
    [Population pharmacokinetics]
    1998
  66. Lejko-Zupanc Tatjana
    Zdravljenje okužb z zajedalci
    [Treatment of parasitic infections]
    2000
  67. Irman-Florjanc Tatjana
    Farmakokinetika zdravil v starosti
    [Pharmacokynetics of the medicines in the old age]
    1999
  68. Irman-Florjanc Tatjana
    Farmakokinetika zdravil za zdravljenje glavobola
    1998
  69. Lopuh Mateja
    Farmakokinetika in farmakodinamika opioidnih učinkovin
    1998
  70. Manohin Aleksander
    Farmakokinetika in farmakodinamika hlapnih anestezijskih učinkovin
    1998
  71. Kalan Gorazd
    Farmakokinetika glukoza-1-fosfata u liječenju hipofosfatemije umjetno ventilirane nedonoščadi s hijalinomembranskom bolešću
    [Pharmacokinetics of glucose-1-phosphate in premature babies with idiopathic respiratory distress syndrome in substitutional therapy of hypophosphatemia]
    1996
  72. Francetić Igor
    Farmakokinetika antimikrobnih lijekova i značenje antimikrobnih lijekova u liječenju crijevnih infekcija
    1997
  73. Kozjek Franc; Palka Edvard; Križman Igor; Vodopivec Polona
    Pharmacokinetics of ciprofloxacin metal complexes
    [Farmakokinetika kovinskih kompleksov s ciprofloksacinom]
    1996
  74. Est M
    Farmakodinamika in farmakokinetika najvažnejših psihoaktivnih snovi
    [Pharmacodynamic and pharmacokinetic properties of the most commonly used psychoactive substances]
    1993
  75. Plavšić F
    Farmakokinetika ciklosporina
    1991
  76. Plavšić F
    Farmakokinetika
    1991
  77. Mrhar A; Kozjek F; Karba R
    Farmakokinetika antiulkusnih zdravil
    1991
  78. Šušković S; Lenardič A; Urbančič J; Jurčič B
    Farmakokinetika tableta Teolin 300 i kapsula Teotard 350 u astmatičara
    [Pharmacokinetics of tablets Teolin 300 and capsules Teotard 350 in asthma patients]
    1990
  79. Kozjek F
    Farmakokinetika u starijih osoba
    [Pharmacokinetics in the elderly]
    1989
  80. Kopitar Z
    Farmakokinetika fluoriranih kinolonov
    [Pharmacokinetics of fluorinated quinolones]
    1990
  81. Mrhar A; Kozjek F; Karba R
    Farmakokinetika antiulkusnih zdravil
    1990
  82. Strle M
    Farmakokinetika lokalnih anestetikov
    1988
  83. Kmet D
    Farmakokinetika in farmakodinamika analgetikov
    1988
  84. Kozjek F
    Farmakokinetika antagonista H2-receptora
    1988
  85. Nadjafi C
    Farmakologija aminoglutetimida - farmakokinetika, farmakodinamika, mehanizam djelovanja
    1988


Nova poizvedba      Pripombe      Na vrh strani                        Inštitut za biostatistiko in medicinsko informatiko